Lake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Ben Haynor maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and lowers the price target from $7.5 to $7.
Lake Street analyst Ben Haynor maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and lowers the price target from $7.5 to $7.